Valency Biofarma Private Limited - Company Profile

It is a paper private limited company based in Panvel, Maharashtra, India, established in 2023.
2023 Panvel, Maharashtra, India Active
Last Updated:
Access Report
About Valency Biofarma Private Limited

Valency Biofarma Private Limited, a active private limited company, was established on 30 October 2023 in Panvel, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001MH2023PTC413051. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sadhna Tiwari (Director), Sanjeev Kumar Tiwari (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Comm-7Pl-191To197-199-206, Sec-10 Prajapatiornpanvel, Panvel, Maharashtra, 410206.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001MH2023PTC413051

  • Registration Number

    413051

  • Incorporation Date

    30 October 2023

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Valency Biofarma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Valency Biofarma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Valency Biofarma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sadhna Tiwari Director 30 Oct 2023 Current
Sanjeev Kumar Tiwari Director 30 Oct 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Valency Biofarma.

Enhance accessibility to Valency Biofarma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Valency Biofarma revenue growth over time
Valency Biofarma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Valency Biofarma?

Unlock access to Valency Biofarma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Valency Biofarma?

Unlock and access historical data on people associated with Valency Biofarma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Valency Biofarma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valency Biofarma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Valency Biofarma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Valency Biofarma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Valency Biofarma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Sadhna Tiwari was appointed as a Director was appointed as a Director on 30 Oct 2023 & has been associated with this company since 2 years 3 months . was completed.

  • Director Appointment

    Sanjeev Kumar Tiwari was appointed as a Director was appointed as a Director on 30 Oct 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.

  • Company Incorporation

    Valency Biofarma Private Limited was registered on 30 Oct 2023 with Roc Mumbai & aged 2 years 3 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Valency Biofarma Private Limited?

The CIN of Valency Biofarma Private Limited is U21001MH2023PTC413051.

Where is Valency Biofarma Private Limited headquartered?

Valency Biofarma Private Limited is headquartered at Comm-7Pl-191To197-199-206, Sec-10 Prajapatiornpanvel, Panvel, Maharashtra, 410206.

When was Valency Biofarma Private Limited incorporated?

Valency Biofarma Private Limited was incorporated on 30 October 2023.

Who are the current directors of Valency Biofarma Private Limited?

The current directors of Valency Biofarma Private Limited are

What is the primary industry of Valency Biofarma Private Limited?

The primary industry of Valency Biofarma Private Limited is Paper.

Is Valency Biofarma Private Limited a listed company?

Valency Biofarma Private Limited is unlisted.

What is the capital structure of Valency Biofarma Private Limited?

The authorized capital of Valency Biofarma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available